CompaniesByCap
EQ
Equillium, Inc. (EQ)
NASDAQ · Healthcare

Equillium, Inc. Revenue 2022–2024

Equillium, Inc. annual/quarterly revenue history and growth rate from 2022 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Equillium, Inc. revenue for the quarter ending September 30, 2024 was 12.2 M, a 37.10% increase year-over-year.
  • Equillium, Inc. revenue for the twelve months ending September 30, 2024 was 45.6 M.
  • Equillium, Inc. annual revenue for 2024 was 41.1 M, a 13.89% increase from 2023.
  • Equillium, Inc. annual revenue for 2023 was 36.1 M, a 128.97% increase from 2022.
  • Equillium, Inc. annual revenue for 2022 was 15.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Equillium, Inc. (EQ) — Frequently Asked Questions

Equillium, Inc. (EQ) is a publicly traded US company. It has a market capitalization of $94M. In fiscal 2024 it reported revenue of $41M and net income of -$8M. Explore EQ's stock price, financial statements, earnings history, margins and key ratios below.

What is Equillium, Inc.'s market cap?

Equillium, Inc. (EQ) has a market capitalization of $94M.

What is the EQ stock price?

EQ trades at $2.67 (-1.11% on the day).

How much revenue does Equillium, Inc. make?

Equillium, Inc. reported revenue of $41M in fiscal 2024.

Is EQ profitable?

In fiscal 2024, Equillium, Inc. reported net income of -$8M.

EQ Stock — Equillium, Inc. Price, Earnings & Analysis | CompaniesByCap